Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · August 15, 2022

Association Between Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients With Primary Progressive MS

JAMA Neurology

 

Additional Info

Disclosure statements are available on the authors' profiles:

JAMA Neurology
Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients With Primary Progressive Multiple Sclerosis
JAMA Neurol 2022 Jul 25;[EPub Ahead of Print], E Portaccio, M Fonderico, P Iaffaldano, L Pastò, L Razzolini, A Bellinvia, G De Luca, P Ragonese, F Patti, V Brescia Morra, E Cocco, P Sola, M Inglese, G Lus, C Pozzilli, D Maimone, A Lugaresi, P Gazzola, G Comi, I Pesci, D Spitaleri, M Rezzonico, M Vianello, C Avolio, FO Logullo, F Granella, M Salvetti, M Zaffaroni, G Lucisano, M Filippi, M Trojano, MP Amato

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading